Information about SaveRxCanada.to
List of countries where we can ship Nilotinib:
Latest news releases on Nilotinib:
Nilotinib (AMN107, trade name Tasigna), in the form of the hydrochloride monohydrate salt, is a small-molecule tyrosine kinase inhibitor approved for the treatment of ...
Learn how TASIGNA® (nilotinib) can be prescribed to treat Ph+ positive chronic myeloid leukemia. See full Safety & Prescribing Info and BOXED WARNING.
Nilotinib: learn about side effects, dosage, special precautions, and more on MedlinePlus
Professional guide for Nilotinib. Includes: pharmacology, pharmacokinetics, contraindications, interactions, adverse reactions and more.
Easy to read patient leaflet for Nilotinib. Includes indications, proper use, special instructions, precautions, and possible side effects.
Nilotinib, also known as AMN107, is a tyrosine kinase inhibitor under investigation as a possible treatment for chronic myelogenous leukemia (CML). In June 2006, a ...
This page contains brief information about nilotinib and a collection of links to more information about the use of this drug, research results, and ongoing clinical ...
Find information about Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML), including causes and how it affects the body.
Find information for HCPs about TASIGNA, indicated for newly diagnosed or imatinib-resistant or -intolerant Ph+ CML. See full Prescribing & Safety Info.
Nilotinib is an orally bioavailable aminopyrimidine-derivative Bcr-Abl tyrosine kinase inhibitor with antineoplastic activity. Designed to overcome imatinib ...